How Accurate Is a Non-Invasive Prenatal Test?
Learn how accurate NIPT (non-invasive prenatal testing) is in 2026. US guide explains cell-free DNA screening sensitivity, false positives, and next steps.
A non-invasive prenatal test (NIPT) is a blood-based screening that analyzes cell-free DNA from the placenta to assess the risk of common chromosomal conditions such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. In 2026, NIPT is considered the most accurate first-trimester screening option available in the United States, with detection rates exceeding 99% for trisomy 21 and a very low false-positive rate of less than 0.1%. However, it is important to understand that NIPT is a screening test, not a diagnostic test; a positive result should be confirmed with chorionic villus sampling (CVS) or amniocentesis.
Understanding NIPT Accuracy: Key Metrics
Accuracy is measured by sensitivity (how often the test correctly identifies a condition) and specificity (how often it correctly rules out a condition). For trisomy 21, NIPT sensitivity is typically above 99%, and specificity is above 99.9%. For trisomy 18 and 13, sensitivity ranges from 97% to 98%. These numbers are based on large clinical studies and real-world data from US laboratories. The negative predictive value (NPV) is extremely high, meaning a low-risk result is very reassuring.
Factors That Influence NIPT Accuracy
- Fetal fraction: The proportion of cell-free DNA originating from the placenta. A fetal fraction below 4% may lead to a failed or less reliable test. Most US labs require a minimum of 4%, and repeat blood draws are often successful.
- Maternal weight: Higher maternal body mass index can lower fetal fraction, slightly reducing accuracy. Labs adjust for this.
- Multiple gestations: In twin pregnancies, NIPT remains highly accurate for trisomy 21, but accuracy for each individual fetus may be slightly lower. Some labs offer twin-specific algorithms.
- Vanishing twin: A demised twin can release its own DNA, potentially causing a false positive. Genetic counselors often recommend confirmatory testing in such cases.
Comparison of NIPT with Other Prenatal Screening Methods
To put NIPT accuracy in context, the table below compares it with other common US screening tests. None are diagnostic; CVS and amniocentesis are the gold standards for diagnosis.
| Screening Test | Trisomy 21 Detection Rate | False-Positive Rate | Typical Timing |
|---|---|---|---|
| NIPT (cell-free DNA) | >99% | <0.1% | 10–22 weeks |
| First-trimester screening (nuchal translucency + blood) | 82–87% | 5% | 11–13 weeks |
| Quad screen (second-trimester) | 75–80% | 5% | 15–22 weeks |
| Integrated screening (first + second trimester) | 90–95% | 2–3% | First + second trimester |
What NIPT Does and Does Not Screen For
Standard NIPT screens for trisomy 21, 18, and 13. Many US labs also offer expanded panels that include sex chromosome aneuploidies (e.g., Turner syndrome, Klinefelter syndrome) and certain microdeletions (e.g., 22q11.2 deletion syndrome). However, NIPT does not screen for neural tube defects, structural anomalies, or most single-gene disorders. For those, additional carrier screening and ultrasound are needed. A genetic counselor can help interpret results and recommend follow-up.
The Role of Carrier Screening Alongside NIPT
Many US patients choose to combine NIPT with carrier screening (e.g., for cystic fibrosis, spinal muscular atrophy, fragile X syndrome) to get a more comprehensive risk picture. Carrier screening is performed on the mother’s blood and looks for recessive gene mutations. When both parents are carriers, there is a 25% chance the child will be affected. Ordering a combined prenatal screening panel that includes NIPT plus carrier screening is a common and efficient approach.
False Positives, False Negatives, and Confirmatory Testing
Even with NIPT’s high accuracy, false positives can occur—especially for rare conditions like trisomy 13 or microdeletions. The positive predictive value (PPV) depends on the condition’s prevalence and the patient’s age. For example, for trisomy 21 in a 35-year-old woman, PPV is about 90%; for a 25-year-old, it may be lower. False negatives are extremely rare but possible. Because NIPT is a screening test, the American College of Obstetricians and Gynecologists (ACOG) recommends that all positive results be confirmed with diagnostic testing (CVS or amniocentesis). Both carry a small risk of miscarriage (roughly 1 in 300 to 1 in 500 for amniocentesis, and slightly higher for CVS).
How to Order a Prenatal Screening Panel
If you are ready to take the next step, you can order a prenatal screening panel online and receive your results quickly through a secure portal. The panel includes NIPT plus comprehensive carrier screening, giving you a thorough understanding of your baby’s risk for common genetic conditions. Remember, this information is for educational purposes and does not replace a consultation with your healthcare provider or a genetic counselor.
Ready to get screened? Order a prenatal carrier screening panel online through our partner and visit a local lab near you.
Order Prenatal Carrier ScreeningAbout PrenatalScreenings
PrenatalScreenings.com is a local lab information directory. We do not provide medical advice, diagnose conditions, or interpret test results. Always consult a qualified healthcare provider for personal medical guidance.